STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Haemonetics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) announced that CEO Chris Simon will present at the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, at 8:45 a.m. ET. Investors can access the live presentation via a webcast, with a replay available for 180 days post-event, starting at 12:00 p.m. ET. Haemonetics focuses on innovative medical products to enhance patient care and improve healthcare costs.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+1.75% News Effect

On the day this news was published, HAE gained 1.75%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOSTON, Aug. 23, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022, at 8:45 a.m. ET.

The public may access Mr. Simon's presentation live via webcast and subsequent replay at: https://event.webcasts.com/starthere.jsp?ei=1566655&tp_key=6a9e8b9f64&tp_special=8

A replay of the webcast will be available for 180 days beginning on September 12, 2022 at 12:00 pm ET using the webcast link provided in this press release.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.     

Investor Contacts:


Olga Guyette, Sr. Director, Investor Relations & Treasury

David Trenk, Manager, Investor Relations

(781) 356-9763

(203) 733-4987

olga.guyette@haemonetics.com

dtrenk@haemonetics.com



Media Contact:


Josh Gitelson, Director, Global Communications


(781) 356-9776


josh.gitelson@haemonetics.com


 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference-301611157.html

SOURCE Haemonetics Corporation

FAQ

When is the Haemonetics presentation at the Morgan Stanley Healthcare Conference?

The presentation will take place on September 12, 2022, at 8:45 a.m. ET.

How can I access the Haemonetics webcast during the presentation?

The webcast can be accessed live via a link provided in the press release.

Will there be a replay available for the Haemonetics presentation?

Yes, a replay will be available for 180 days starting from September 12, 2022, at 12:00 p.m. ET.

What is Haemonetics known for?

Haemonetics is known for providing innovative medical products and solutions to improve patient care and reduce healthcare costs.
Haemonetics Corp Mass

NYSE:HAE

HAE Rankings

HAE Latest News

HAE Latest SEC Filings

HAE Stock Data

3.92B
46.23M
1.15%
115.65%
7.61%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
BOSTON